Good morning, afternoon, evening. My name is Catherine, and I will be your conference operator today. Today's call is being recorded, and at this time, I'd like to welcome everyone to Savaria Corporation's Quarter Two 2021 Conference Call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a questions and answer session.
If you'd like to ask a question during this time, simply press star and then one on your telephone keypad. If you would like to withdraw your question, please press star two. This call may contain forward-looking statements, which are subject to the disclosure statement contained in Savaria's most recent press release issued on the August the 11th, 2021 with respect to the quarter two 2021 results. Thank you. Mr. Bourassa, you may now begin your conference.
Thank you, Ms. Catherine. We have a very interesting Q2 that we put in the press release that we gave yesterday. We find that our acquisition of Handicare, it's even more interesting than ever. I think that's a perfect fit with, excuse my English, Savaria. That's a good complement. A good complement on talents. Talents is always very important when we make an acquisition, and after that, a good complementary on their operation. I think they are outstanding the way that they manufacture a curved stairlift.
What is very interesting, we will have this equipment of manufacturing, a curved stairlift, that will begin by the end of the year in Toronto to manufacture these outstanding products, and the way that they manufacture that. We will learn from that, and after that, a curved stairlift can be delivered in the maximum three days after the orders. That's very impressive, and I like it very much. They bring- t hat's important- t hey bring that to our company, they bring the cross-selling of our products, of our house to other people in Europe. We are going to begin to make some cross-selling and thank them.
A big improvement would be by the people of Handicare. That's their niche. They know about that. I think that will change our vision of selling Savaria products in Europe and other countries. We speak about yesterday, about the CAD 100 million. That we're comfortable with this number. We speak about reaching our goal of CAD 1 billion by 2025. We are very happy what we see to reach this number without key acquisition and just maybe a small one.
My people, my specialists, we speak about that. My specialists are there on the phone. We will begin the questions shortly. I just want to say, we see some residential , strongly, order, and we see that the commercial will come slowly after the pandemic will be resolved a little bit. We are very enthusiastic about that. We will begin the call, Catherine. Thank you for your introduction.
Mr. Rimbert, Mr. Sébastien, and Steve are on the call to answer to you guys. Again, thank you to be part of our story. Because the story, we need people to see our story, our great story. That's another great chapter that we have this morning. Plus, we have MaisonBrison, that will work for Savaria in Communication. Thank you, mister - for the house, and Mr. Boucher to be the head of this MaisonBrison. They are very good in communication. Thanks again. Go. We are ready, Catherine, for the call.
Thank you, Marcel. Basically, let me start to discuss the progress on the integration with Handicare. The second quarter was the first quarter to include the full contribution of Handicare. We had a very good start to our integration plan. We set up multiple committees that meet every two weeks to discuss opportunities and make sure we keep on track. These committees have been mostly meeting on Teams so far, but with travel restriction lifting, we have begun to meet in person, which give us a much better perspective.
Example, in Q2, we had a chance to go to [Sanctuith] to meet the team [over Wendy's] to discuss about the patient handling. We have met in person with a team of Handicare in Toronto. In terms of synergies, we started to look at both costs of goods sold and indirect costs, including corporate costs linked to being a public company, purchasing, integrating some of our products. While we are making some headway on those savings, aside from certain administration savings, most of these are not reflected in our results of Q2 as we're still in early days.
A major project on the way is a capital investment at our factory in Toronto to accommodate the production of the Freecurve stairlift for Handicare. The layout of the new production line has been designed. Special equipment has been ordered from Europe, including welding robot, bending machine, and we have begun to train our engineering team. We are continuing to expect to start production by the end of Q4.
The project will bring a high degree of automation to our factory in Toronto and will cut lead time, as Marcel said, from two to four weeks to three days, providing us a significant competitive advantage. Thank you to the team in Netherlands and we should meet by week. I will now pass it on to Nick for some cross-selling initiatives.
Thank you, Sébastien. With respect to cross-selling, we've begun an in-depth review of our respective product lines, both within accessibility and patient handling. Our sales leaders are working together and currently laying the groundwork for a collaborative commercial strategy across all our brands. We're managing and organizing our dealer channels in the U.S. and Canada to accommodate the significant interest we've received for North American-made curved stairlifts. In Europe, we've introduced our broader accessibility lineup to Handicare sales team, including our Vuelift glass elevator.
Handicare dealers in Europe have also begun placing the first orders for Garaventa's inclined platform lift. Within patient handling, we are exploring how best to optimize our sales efforts to better serve our customers. This will involve the introduction of Span bed frames and pressure care products within Handicare sales channels, collaborating on a joint sling line and leveraging Handicare service and installation infrastructure. We're also looking to jointly attend industry trade shows, further bringing our sales teams together. While cross-selling takes the most time to set up and develop, in the long term, we believe it has the most upside potential.
However, we should not expect meaningful results from these activities in the short term, as our people need time to learn the products and how best to sell them. While we're in the midst of our integration with Handicare, we're still looking, I guess, to do some tuck-in acquisitions, and as we mentioned in the past, these might include a dealer in a strategic region or a small manufacturer of a complementary product. We're well-positioned to take advantage of these opportunities as they arise. With that, I'll pass it back to Sébastien for some brief comments.
Thank you, Nick. I just want to bring to your attention a few supply chains challenge we have experienced in our business recently. Like many other companies, we have faced headwinds with regards to supply chain delays in receiving our orders, a significant increase in our cost of container, difficulty to hire direct labor. We do our best to continue to be proactive, despite these challenge, we were able to deliver a strong results in the quarter. We have recently implemented some price increase to a customer in most of our brands to help mitigate inflation. We are hopeful to see some small margin improvement in Q4. I will now turn it on to Steve for a financial review.
Thanks, Sébastien, and good morning, everyone, and thanks for being on the call this morning. I'm gonna begin with some remarks regarding our Q2 2021 consolidated financial metrics. For the quarter, the corporation generated revenue of CAD 179 million, more than double the CAD 85 million reported in the second quarter last year, mainly due to the acquisition of Handicare. Gross profit and gross margins sit at CAD 65 million and 36.5% respectively, compared to CAD 29 million and 34.6% for the corresponding period last year.
The increase in gross profit over prior year was attributable to a favorable product mix with the acquisition of Handicare. Adjusted EBITDA and adjusted EBITDA margins sit at CAD 27.4 million and 15.3% respectively, compared to CAD 14.5 million and 17.1% in Q2 2020. Significant increase in adjusted EBITDA was mainly attributable to the acquisition of Handicare and ongoing corporation-wide cost containment efforts, partially offset by a reduction in the COVID-19 employment retention Government of Canada subsidies.
Turning now to segmented results. Revenue from our accessibility segment was CAD 130.8 million in Q2 2021, more than double when compared to CAD 60.2 million generated in Q2 2020. The increase in revenue is mainly attributable to the acquisition of Handicare, which contributed an increase of 109.6%, and also organic growth of 12.4%, driven by the economic recovery from the global pandemic. This growth was partially offset by a negative foreign currency impact of 4.8% for the quarter. Adjusted EBITDA and adjusted EBITDA margin, both before head office costs, stood at CAD 23.4 million and 17.9% respectively, compared to CAD 12.3 million and 20.4% for Q2 2020.
The significant increase in adjusted EBITDA is due to the acquisition of Handicare, while the decrease in adjusted EBITDA margin is due to the reduction in the COVID-19 employment retention Government of Canada subsidies, partially offset by cost containment efforts. Revenue from our patient handling segment was CAD 36.1 million for the quarter, an increase of CAD 14.8 million or 69.7% when compared to Q2 2020. This increase was primarily driven by the acquisition of Handicare, which contributed 77.3% of growth, partially offset by the negative foreign currency impact of 7.7% for the quarter.
Adjusted EBITDA and adjusted EBITDA margin, both before head office costs, stood at CAD 4.7 million and 12.9% respectively, compared to CAD 2.8 million and 13% for Q2 2020. Similarly to the accessibility segment, the significant increase in adjusted EBITDA is due to the acquisition of Handicare, while the decrease in adjusted EBITDA margin is due to the reduction in COVID-19 employment retention government of Canada subsidies, partially offset by cost containment efforts.
Revenue from the adapted vehicle segment was CAD 11.7 million, an increase of CAD 8.6 million or 270.7% when compared to the same period in 2020. Adjusted EBITDA and adjusted EBITDA margins, both before head office costs, finished at CAD 1.3 million and 11.2%, respectively, compared to negligible amounts in Q2 2020. The increases in revenue and adjusted EBITDA and adjusted EBITDA margin when comparing Q2 2021 to Q2 2020 were again mainly due to the acquisition of Handicare, the economic recovery from the global pandemic, and partially offset by a reduction in COVID-19 employment retention Government of Canada subsidies.
In Q2 2021, net finance costs stood at CAD 5.4 million, up CAD 3.9 million from the CAD 1.5 million for the same period last year. The increase is mainly due to higher interest expenses as a result of additional long-term credit facilities related to the acquisition of Handicare. Net earnings reached CAD 6.6 million or CAD 0.10 per diluted share compared to CAD 6.1 million or CAD 0.12 per diluted share for the corresponding period last year. When we exclude one-time costs, adjusted earnings were at CAD 9.5 million or CAD 0.15 per share, up over 50% versus CAD 6.3 million or CAD 0.12 per share for the corresponding period last year.
We're going to turn to capital resources and liquidity. Driven by the solid profitability, Savaria generated cash flow from operations of CAD 14.4 million in the quarter. We used this cash to primarily reduce debt, invest in capital projects and pay dividends. As of June 30th, 2021, the corporation had a net interest-bearing debt position of CAD 279 million and was in compliance with all of its covenants.
On a pro forma last 12 months adjusted EBITDA basis, the corporation's debt to adjusted EBITDA ratio was approximately 3.5 times. Savaria has liquidity in excess of CAD 125 million to fund future projects and investments across the company. Now taking a look forward, the uncertainty around the future impacts of the ongoing global pandemic makes it difficult to predict future performance.
However, considering our financial performance year-to-date with an adjusted EBITDA of CAD 44.7 million, coupled with current backlog levels and our confidence in the strategic integration plan with Handicare, we remain optimistic we will achieve our previously stated goal of generating an adjusted EBITDA in excess of CAD 100 million for fiscal 2021. Please refer to our MD&A for the underlying assumptions used to prepare this guidance. With a strong product portfolio reaching over 40 countries, our increased distribution network, combined with growing demand for mobility products, we are very well positioned for future growth. On that note, I will turn the call back over to Marcel.
Thank you, Steve. Thank you, Nicolo and Sébastien, to make your comments . You know, the guy, the people who know me since 20 years . My English is not improving at all, okay. Excuse me for that . The other thing I can say, right now, our ratio debt of EBITDA, seems high a little bit, but what we see, coming in the next two years, I am not nervous at all, to have this ratio, right now over three, but going back smaller, in a couple of years. That was it.
Thank you for my guys, but you can read that on our MD&A. What is very important, is your question that you have to ask to our guy- my guy, okay, or to myself. Catherine, can you do some question from our people? To our analysts.
Thank you. If you would like to ask a question, please signal by pressing star one on your telephone keypad. If you are using a speaker phone, please ensure that you have turned off the mute function is turned off to allow the signal to reach our equipment. We'll just pause for a moment so that everyone has an opportunity to signal for a question. We'll now take the first question from Derek Lessard at TD Securities. Please go ahead.
[Foreign language]There's a lot going on, but my first question is maybe on the organic revenue growth, probably the best you've seen in two years. I know you did point to the [Garaventa] recovery, but just wondering if there was anything else driving that number that you'd like to highlight.
Steve?
Yeah. Well, Derek, with respect to organic revenue growth, and again, thank you for highlighting about it's been the highest in a couple of years here. It's really on the back of the residential sector that continues to be very, very strong. In terms of what we would highlight is just that the commercial hasn't come back yet. I think that a lot of the landlords and various of these building owners, they're waiting to see sustained foot traffic before they make certain investments. Right now it's really being driven by the residential, which is carrying us through here. That's, I guess, probably the best color I can give you as it relates to what's driving the organic growth and accessibility.
Okay. Maybe just to switch gears, I'm curious on your view with respect to the evolution of margins this year, particularly as you mentioned, you're dealing with numerous disruptions to the supply chain. I guess I'm particularly curious about how it relates to some of the Handicare synergies, and maybe on your lead times and ability to meet your current customer demands.
Okay, Derek, maybe Sébastien will comment after me, okay? Me, I see very organic growth in the future. Something that was not very good on the last couple of years about our growth. I share with my people that we have to be better. We were better in Q2, and we will continue to be a lot better by this mix of products right now available to Handicare. In the past, they were selling just straight stairlift and curved stairlift on accessibility project.
Right now they have our house. All our products is accessible for our people in Europe, and other country. It's quite exciting. Mr. Rimbert mentioned that it's not overnight that we can make all this synergy, but it will come, because the dealer prefer to buy more product from the same place. They know what kind of service they can have right now with Handicare, and that will lead just a very good complement to Handicare with our team to carry the service and installation and everything.
I think that will be driving this, what we will see in the coming years. I am quite excited to be in this mix of products that we can offer to anybody. I think the growth will be there. I am very optimistic what we have to see. More important, I signal that in the beginning, this is a good acquisition. Good people from Garaventa, that's another good complement to their product. We will see some good increase on that, Derek. Sebastian, you have some more to add?
Yeah, I think, Derek, that's a very good question, and I think sometimes we have to be careful the way we answer because sometimes we have competitors listening on the call. If you go back to what is public, we say that in the first two years, we'll make CAD 12 million of synergy, and it was mostly a few baskets. The curved stairlift, which we are doing in Toronto, there's more opportunity on purchasing, maybe not the best year because of inflation, but definitely purchasing, we are looking at it.
Cross-selling, we said it started with the Vuelift in Europe. The stairlift will happen next year with some of the dealers around Garaventa with Handicare in Toronto. I think the early time, yes, it’s a bit longer than it was before, not because necessarily of supply chain. Our backlog is quite high right now on the residential sector. Maybe we are one or two weeks more than we were in the past.
Okay, thanks for that. Maybe just one housekeeping for Steve. Can you just give us the cadence and maybe a level of CapEx we should expect, particularly given the investment in the Toronto plant?
A significant part of the Toronto plant investment has actually already been made. That project, I'd say we're probably half spent on that already. Our level of CapEx on a go-forward basis is gonna be in line with our Q2 run rate and year-to-date where we're sitting.
Okay, thank you.
We'll now take the next question from Michael Doumet at Scotiabank. Please go ahead.
Hey, good morning, everybody.
[Foreign language]
The first question, hi. The first question again on legacy accessibility. You've indicated, again, on this call as well, in the last couple of quarters, it's been very strong residential and commercial's lagged. Are you getting market signals that commercial is on the cusp of a rebound? I guess the way I'm thinking about it, if we're not seeing that now with the reopening, when should we expect that to start to play out?
Mr. Rimbert will complement my answer to that. You know that many commercial sites were not in operation during the pandemic, and are not in operation even right now. It will take maybe a little time, but all the improvement on commercial, part of that has to be accessible to these people that need more mobility. I would ask Mr. Rimbert to complement a little bit my answer.
Yeah. Sure, Marcel. It is difficult, Michael. We don't have a crystal ball that tells us exactly what quarter it's going to pick up. I guess in our minds, it's just a question of, it's more when as opposed to if. A lot of these commercial investments that we're seeing, these upgrades to various buildings, they're waiting, right? I'm not sure if you've been downtown recently, but it's still, I won't say a ghost town, but the foot traffic is much, much lower than what we've seen previously.
Even the economies are opening up, it is taking some time for restaurants to have the confidence. They're just trying to hire staff and bring people back in. Schools as well. We're seeing schools open up, and then in certain areas, schools are going back virtual because of these smaller outbreaks that are happening. I think there's just a lot of uncertainty on the commercial space.
Before they're making those investments, they do want to see a more sustained recovery. With that being said, I think, to our previous comment, the residential is really carrying us here in organic growth, which is very positive, and we're seeing some very good momentum there. Commercial, whether it's this quarter or next quarter, it will come back, and that will help sustain that momentum in organic growth. We're not overly nervous about it. We have, as Sébastien mentioned, a very good backlog as it relates to our residential orders. We're quite confident where we are now, and when commercial does come back, we'll be prepared.
All right. That's very helpful. Thank you. Maybe just on the residential, quarter-over-quarter, has the backlog strengthened at this point? Just from, I guess, if you're tracking residential permits, trying to get a sense for if you're still seeing positive momentum in residential here.
Well, maybe Sébastien will complement me on that. I can see, me, I see the number. The number is quite important, okay? We see our residential elevators, our order is triple what we have last year at the same time. It's why we are very optimistic when we speak to our dealers. Even on the direct installation, we are very strong number from where we have direct installation. For sure the dealer is very important in our operation, and they are very optimistic with what they have orders with us. I think it's just nice sales coming. Sébastien, you want to complement my answer?
I think we are very lucky. We have a good backlog in residential, so that give us a bit of more certainty for the end of the year to make sure we can have a good growth again. I think for sure, we have done a lot of marketing activity on our Vuelift. We don't always end up with the sales of Vuelift. Sometimes we end up with other products like Eclipse or Infinity. Definitely, we have been doing quite good on the residential sector, and I think the pandemic has helped. People still don't travel. They want to stay home, do a lot of projects. Definitely, we are lucky.
Great. Maybe just one more, and thanks for the color, by the way, but I wanted to ask a question on the new line in Brampton for stairlifts. Can you talk to the additional capacity that's expected to come online? I guess from what I've understood, Handicare has been shipping stairlifts to North America through freight. Therefore, I guess, should we think about the sales coming online out of Brampton as replacing the old sales, or should they be incremental? I'm just trying to gauge whether this is a revenue story or a margin story at first.
If you want, I can go. Okay. I think it's a combination of both. Definitely, we were a bit subsidizing the freight, we are doing it to save some freight. The biggest thing is really the opportunity to manufacture curved stairlift in a short lead time. We are going to see a lot of cross-selling.
At the beginning of the project, my team asking, "Well, why are you buying all the robots, Sebastian? They are going to sleep. They are not going to work." I say, "Guys, no worry about it. We are doing it for the future." Definitely, we are planning to do much more than what is the sales of Handicare right now. We're going to be ready to have a good year next year on the curved stairlift.
To add on that, I will add a little complement on that, you know that over years, a product that is very good on the margin, over 20%, is this curved stairlift. That will be a major product for us in the future with this help of manufacturing ourselves and delivering in three days all across North America. I don't want to be too much optimistic, but I am very optimistic about to manufacture something and deliver that in less than three days. Thank you for your questions. Next one, please.
We'll now take the next question from Nick Agostino at Laurentian Bank Securities. Please go ahead.
Hi, Nick.
[Foreign language] and good morning, and congrats on the results. Very impressive. Certainly applaud the organic growth rate. I guess my questions first is on the patient handling and ceiling lift. You guys talked about, I guess, realizing cost synergies. As we all know- I think Handicare has done a good job when it comes to ceiling lift sales in general. I'm just wondering from a sales -synergy perspective, is there anything that you guys have learned that you can use when it comes to selling the ceiling lift into the North American market? Your product, that is, that these guys were already doing from a marketing or just sales in general.
Nick will answer this question after me, okay, but just to mention, I speak about accessibility, okay, but our product from Span and Handicare on the patient lift, that represents directly 20% of our sales. We have not to forget that, okay? I think the clustering of the two company on that will be just the future with when we will be full-time knowing exactly where it sells, where to combine some sales. I think it will be great, but I am sure that Nicolas is more appropriate to answer to you, Nick. Nicolas?
Yeah. Thank you, Marcel. In terms of what we've learned, I believe that was your question, Nick. What maybe we've learned from Handicare for our own operations in terms of selling more ceiling lift product in North America. First, I would say that the ceiling lift and sling part of the business was actually very strong in the second quarter, and it has been for most of the year. There's been a very good rebound in sales of those products and those categories. Again, Handicare contributed much of that in the quarter.
What we're seeing and what we're working on together is trying to put our sales forces together and realize where we might be able to open up more pockets of growth for us, whether it be going into certain of Span's channels, which are complementary to Handicare's channels, whether it be looking at the products that we have and seeing where we might be able to use the best of both, right?
If there's certain R&D projects that we're working on independently, maybe we join forces there and see if we can be a bit more efficient in how we go about our R&D spending and in development. There's a lot to do on both the synergy side, whether it be on the tracks. That is something as well, looking at how the tracks are installed. We're looking at whether it be utilizing Handicare's.
I think I mentioned that in the call, their service installation infrastructure to promote, I guess, not only maintenance programs on some of our existing products where we weren't necessarily able to service them, but also looking at how we might be able to leverage them when we're looking at our own contracts, where currently we don't necessarily have our own installation capacity and we're using third parties.
Maybe those are opportunities for us to now use Handicare's folks to do that work. There's a lot that we're working on. It's still early days. The cross-selling is maybe the biggest potential for us, both on patient handling and accessibility. It does take the most time for it to really develop and percolate there. Please follow up with us in the subsequent quarters of how those are developing.
Okay. Appreciate that color. My second question is just looking at the, and answer as you wish, but we're halfway through Q3. We certainly hear the optimism when it comes to the EBITDA for the full year. We got the sense as to where residential versus commercial sits. Can you maybe talk to some of the other products, the platforms and just the straight stair sales? Are you seeing upticks as we're moving through the year and into Q3?
Even on the vehicle side, you guys had a nice, I know it's still small, but it's a nice snapback in terms of that demand. Does it look like it's going to be sustainable in the second half of the year? I know in the past, you were restructuring your own division, Adaptive Vehicles, that is, to get it north of 10%. You're there now with the Handicare. How much more margin do you think you can push it higher on the vehicle side as you do your own restructuring?
Okay. Steve will answer after just a little comment that I will do, okay. It's just that I think we will go with that, okay, to a ratio of 13%. For sure, maybe we can have some synergy built together. Don't forget, okay, the people in wheelchair or just need some transportation, okay. I am very optimistic that we can have some growth in that, okay, and meet our objective for a combined 13% in the future. Steve, you have something to add to me?
Yeah. Marcel, maybe I'll take this. Maybe just to start on the beginning of Nick's question there, you'd mentioned the other products. Yes, as you can imagine, straight stairlifts along with curved stairlifts have been performing well going into our residential clients. We talked about platform lifts. Mini-platform lifts, whether it be the vertical platform lifts or the inclined platform lifts, lots of that is sold into the commercial setting. I think we addressed that earlier about commercial is a bit slower. As you can imagine, sales of those products kind of coincide with how our commercial sales are going. Finally, maybe on the vehicles, we did have a good uptick here in this quarter.
It was nice to see the organic growth come back within that segment for us. Handicare has well contributed. When we look at the margins there, I think it was a combination of their business having some good margins, as well as those improvements that you'd mentioned that we're making here in our facility here at Van-Action, I guess, over the past 12 months or so, to kind of realign ourselves for lower production volume. Where the margins go, I mean, it's difficult for us to really kind of guide you there. I think where we are today is a pretty good point, and we'll see over the next quarter or two, we can make some incremental improvements on top of that.
Thank you, Nick.
Thank you, guys.
We'll now take the next question from Zachary Evershed at National Bank Financial. Please go ahead.
Good morning.
Hello, Zach.
Thanks for taking my questions. Most of them have already been answered by the previous questions, so just one for me. I'd be interested to hear about your plans for your marketing program. Can you give us the rundown?
Very good question. I will try to answer that without that I will announce something that is not already announced. We are very fortunate that we make an acquisition, and we're still in good situation to put an aggressive marketing point, marketing strategy to go on cross-selling. Many companies make a huge acquisition, after that, they don't have money. Now we have CAD 125 million to do a good strategic plan on marketing in Europe, and even in the west of the U.S., when we will manufacture in Toronto, the curved stairlift.
I put again that we have CAD 125 million to use to push this association, this great partnership that we have with Handicare. What is the amount? You will have an answer to me next quarter. We have already a strategic plan to push that, but you will see the color of that in our next quarter and our next conference call that we will have in three months. That is my answer.
I'll turn it over. Appreciate it. Thank you.
Thank you.
We'll now take the next question from Louis Jutras at Desjardins Securities. Please go ahead.
Thank you. Good morning.
[Foreign language]
I'm calling on behalf of Frederic Tremblay. Just one question from me. Can you provide more details on your initiatives in Europe? Have you been successful at cross-selling Handicare's product there, and how would you characterize the market's level of interest for the Vuelift currently in Europe? Thank you.
Okay. Thank you. Maybe Sebastian or Nicolas will speak to answer more deeply about this question, okay. It's just a start, okay. We start, okay, since the acquisition on March 4th, okay? It takes time, okay? What is very important at the beginning, okay, is how our team, okay, from Handicare are interested by our products, okay. They are very interested- there's still growth opportunity in that. Nothing is easy, but when you add, some products to an organization , the magic, okay, of synergy is there. We feel, and what's very important, okay, that our team at Handicare are very, very enthusiastic, okay, to work with us to sell our product in Europe.
Maybe after if I compliment, okay.
Yeah.
Basically, where we started to have some small success, if we can call it this way, in Europe, Handicare, they have introduced the Garaventa platform to their dealers, and we already have some small success. Some people have the interest. We have more one-stop shop, so definitely that's a start. Vuelift in Europe, I think Garaventa, it took some time to start, but we are starting a beginning of trend in Germany and in Switzerland, so I think that's a start.
Definitely, we are making some training with the Handicare team and still the Garaventa team every week. That's something which is on the agenda. People know it's important. Definitely, that's going on. The stairlift, I would say North America- yes, some of our dealers has maybe reached to Handicare, but a lot of them are kind of waiting at Toronto start.
That's really, I think next year you will see more numbers on cross-selling of stairlift in North America once we manufacture here. I think that's a start. Of course, we are aligning our R&D for maybe for the future, what we want to do in the future in Europe, okay, some product that we might bring over there. Definitely, a one-stop shop is another pipeline.
Thank you, Sebas.
Thank you. That's helpful. I'll turn it over.
[Foreign language]
It appears there are no further questions at this time. Mr. Bourassa, I'd like to turn the conference back to you for any additional or closing remarks.
Thank you guys to be there for this call. I think, again, our story, our growth story- you have to take care of the communication of that. Thank you very much. Thank you again for MaisonBrison. Thank you my internal guy to participate at this call. Everybody's very enthusiastic. Thank you, and I will see you in three months. Bye.
That concludes today's call. Thank you for your participation. You may now disconnect.